Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Cm 6912
2. Ethyl Flucozepate
3. Victan
1. Victan
2. Meilax
3. 29177-84-2
4. Ethyl Fluclozepate
5. Cm 6912
6. Loflazepic Acid, Ethyl Ester
7. Vjb5fw9w9j
8. Ethyl 7-chloro-5-(o-fluorophenyl)-2,3-dihydro-2-oxo-1h-1,4-benzodiazepine-3-carboxylate
9. 1h-1,4-benzodiazepine-3-carboxylic Acid, 7-chloro-5-(2-fluorophenyl)-2,3-dihydro-2-oxo-, Ethyl Ester
10. Ethylis Loflazepas
11. Ethyl Loflazepate [inn:jan]
12. Loflazepate D'ethyle
13. Loflazepato De Etilo
14. Ethylis Loflazepas [inn-latin]
15. Loflazepate D'ethyle [inn-french]
16. Loflazepato De Etilo [inn-spanish]
17. Einecs 249-489-4
18. Unii-vjb5fw9w9j
19. Brn 0765264
20. Dea No. 2758
21. Meilax (tn)
22. Cm-6912
23. Ethyl 7-chloro-5-(2-fluorophenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepine-3-carboxylate
24. 5-25-08-00124 (beilstein Handbook Reference)
25. Ethyl Loflazepate (jan/inn)
26. Schembl156702
27. Ethyl Loflazepate [mi]
28. Ethyl Loflazepate [inn]
29. Ethyl Loflazepate [jan]
30. Chembl1213460
31. Chebi:31573
32. Dtxsid60865475
33. Ethyl Loflazepate [mart.]
34. Ethyl Loflazepate [who-dd]
35. Db01545
36. Ethyl 7-chloro-5-(2-fluorophenyl)-2-oxo-2,3-dihydro-1h-1,4-benzodiazepine-3-carboxylate
37. D01293
38. Q5404460
39. Ethyl 7-chloro-5-(2-fluorophenyl)-2-oxo-2,3-dihydro-1h-1,4-benzodiazepine-3-carboxylate #
40. (e)-ethyl 7-chloro-5-(2-fluorophenyl)-2-oxo-2,3-dihydro-1h-benzo[e][1,4]diazepine-3-carboxylate
41. Ethyl 7-chloro-5-(2-fluorophenyl)-2-oxo-2,3-dihydro-1h-benzo[e][1,4]diazepine-3-carboxylate
Molecular Weight | 360.8 g/mol |
---|---|
Molecular Formula | C18H14ClFN2O3 |
XLogP3 | 2.9 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 4 |
Exact Mass | 360.0676982 g/mol |
Monoisotopic Mass | 360.0676982 g/mol |
Topological Polar Surface Area | 67.8 Ų |
Heavy Atom Count | 25 |
Formal Charge | 0 |
Complexity | 556 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anti-Anxiety Agents
Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)
N - Nervous system
N05 - Psycholeptics
N05B - Anxiolytics
N05BA - Benzodiazepine derivatives
N05BA18 - Ethyl loflazepate
Registration Number : 228MF10042
Registrant's Address : 1133 Oe, Imizu City, Toyama Prefecture
Initial Date of Registration : 2016-02-08
Latest Date of Registration : --
Registration Number : 302MF10063
Registrant's Address : 1410 Takada, Kashiwa City, Chiba Prefecture
Initial Date of Registration : 2020-06-04
Latest Date of Registration : --
Registration Number : 302MF10056
Registrant's Address : Zhejiang provincial chemical and medical materials base Linhai zone, Linhai, Zhejiang, China
Initial Date of Registration : 2020-05-12
Latest Date of Registration : --
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?